Niki BioSolutions names Ian Huen CEO/Chairman and Alidad Mireskandari President/COO

Aptorum Group Ltd

Ian Huen appointed CEO and Chairman effective Aug 1, 2026; 6-month initial term, HKD 210,000/month (~USD 26,800).
Alidad Mireskandari named President and COO; annual base salary $320,000, rising to $350,000 if $5M capital raised.
Mireskandari receives 20,000 RSUs vesting at merger close and options for 800,000 shares under 2026 Equity Incentive Plan.
Appointments follow July 22, 2026 merger where Niki acquired DiamiR Biosciences; Mireskandari was DiamiR's prior CEO.
Mireskandari severance: 6 months' base salary, increasing to 12 months as of Jan 1, 2027; 2-year initial term.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.